Table 1

Patient and study design characteristics

Study	Treatment period	Sample size		Female gender (%)		Age (year)		Tendinopathy	Minimum symptom duration (month)	Pain outcome	Follow-up (month)
Study	Treatment period	PRP	Control	PRP	Control	PRP	Control	Tendinopathy	Minimum symptom duration (month)	Pain outcome	Follow-up (month)
Behera et al13	2011–2011	15	10	80	50	38	37	Lateral epicondylar	3	VAS	12
de Jonge et al14	2008–2009	27	27	52	52	49	50	Achilles	2	VISA-A	12
Dragoo et al15	2009–2012	A10	13	11	0	28	40	Patellar	1.5*	VAS	6
Gautam et al16	2011–2012	15	15	—	—	—	—	Lateral epicondylar	6	VAS	6
Gosens et al17	2006–2008	51	49	52	56	47	47	Lateral epicondylar	6	VAS	24†
Kesikburun et al18	2011–2011	20	20	65	70	46	51	Rotator cuff	3	VAS	12
Krogh et al‡19	2009–2010	20	20	55	55	48	45	Lateral epicondylar	3	PRTEE	3
Krogh et al‡40	2009–2010	20	20	55	45	48	44	Lateral epicondylar	3	PRTEE	3
Krogh et al20	2009–2011	12	12	42	50	47	52	Achilles	6	VAS	3
Lebiedziński et al21	2009–2011	64	56	47	74	47	54	Lateral epicondylar	1.5	DASH	12
Mishra et al22	2006–2011	112	113	—	—	48	47	Lateral epicondylar	3	VAS	6
Montalvan et al23	2010–2014	25	25	32	32	47	46	Lateral epicondylar	—§	VAS	12
Palacio et al‡24	2012–2014	20	20	—	—	47	48	Lateral epicondylar	—	PRTEE	6¶
Palacio et al‡24	2012–2014	20	20	—	—	47	46	Lateral epicondylar	—	PRTEE	6¶
Rha et al25	2010–2011	20	19	55	58	52	54	Rotator cuff	6	SPADI pain	6
Shams et al26	2013–2015	20	20	50	45	52	50	Rotator cuff	3	ASES	6
Stenhouse et al27	2010–2012	15	13	47	62	53	48	Lateral epicondylar	6	VAS	6
Yadav et al28	2012–2014	30	30	67	77	37	37	Lateral epicondylar	1	VAS	3

‘—’ indicates missing data.
*Patients failed to respond to ≥6 weeks physical therapy; total symptom duration not reported.
†Data extracted through 12 months only for meta-analysis per systematic review methods (ie, data extraction at 3, 6 and 12 months); however, total symptom duration not reported.
‡Study includes same PRP group and different control groups. PRP group sample size adjusted in meta-analysis based on number of groups.
§Maximum symptom duration was 3 months.
¶Data extracted through 3 months only for meta-analysis due to implausible reported 6-month outcomes.
ASES, American Shoulder and Elbow Surgeons; DASH, Disabilities of the Arm, Shoulder and Hand score; PRP, platelet-rich plasma; PRTEE, Patient-Rated Tennis Elbow Evaluation; SPADI, Shoulder Pain and Disability Index; VAS, visual analogue scale; VISA-A, Victorian Institute of Sport Assessment-Achilles questionnaire.